D

Diffusion Pharmaceuticals Inc
NASDAQ:CRVO

Watchlist Manager
Diffusion Pharmaceuticals Inc
NASDAQ:CRVO
Watchlist
Price: 12.54 USD 0.08% Market Closed
Market Cap: 103.5m USD
Have any thoughts about
Diffusion Pharmaceuticals Inc?
Write Note

Diffusion Pharmaceuticals Inc
Total Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Diffusion Pharmaceuticals Inc
Total Assets Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Total Assets Analysis
Latest Figures & CAGR of Competitors

Company Total Assets CAGR 3Y CAGR 5Y CAGR 10Y
D
Diffusion Pharmaceuticals Inc
NASDAQ:CRVO
Total Assets
$10m
CAGR 3-Years
-43%
CAGR 5-Years
-12%
CAGR 10-Years
-16%
Abbvie Inc
NYSE:ABBV
Total Assets
$143.4B
CAGR 3-Years
-1%
CAGR 5-Years
19%
CAGR 10-Years
18%
Gilead Sciences Inc
NASDAQ:GILD
Total Assets
$54.5B
CAGR 3-Years
-7%
CAGR 5-Years
-2%
CAGR 10-Years
7%
Amgen Inc
NASDAQ:AMGN
Total Assets
$90.9B
CAGR 3-Years
12%
CAGR 5-Years
9%
CAGR 10-Years
3%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Total Assets
$22.2B
CAGR 3-Years
21%
CAGR 5-Years
24%
CAGR 10-Years
25%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Total Assets
$37.4B
CAGR 3-Years
17%
CAGR 5-Years
22%
CAGR 10-Years
26%

See Also

What is Diffusion Pharmaceuticals Inc's Total Assets?
Total Assets
10m USD

Based on the financial report for Jun 30, 2024, Diffusion Pharmaceuticals Inc's Total Assets amounts to 10m USD.

What is Diffusion Pharmaceuticals Inc's Total Assets growth rate?
Total Assets CAGR 10Y
-16%

Over the last year, the Total Assets growth was -36%. The average annual Total Assets growth rates for Diffusion Pharmaceuticals Inc have been -43% over the past three years , -12% over the past five years , and -16% over the past ten years .

Back to Top